insulin
- Generic Name
- insulin
Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 165
- Registration Number
- NCT04029480
- Locations
- 🇺🇸
Memorial Regional Hospital-Joe DiMaggio Children's Hospital Division of Pediatric Endocrinology ( Si, Hollywood, Florida, United States
🇺🇸William Beaumont Hospital ( Site 2219), Royal Oak, Michigan, United States
🇺🇸ICCT Research International, Inc. ( Site 2211), Chicago, Illinois, United States
Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT03998709
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Majianhua
- Target Recruit Count
- 74
- Registration Number
- NCT03982238
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, China
Linagliptin in Post-renal Transplantation
- Conditions
- Transplanted Kidney Complication
- Interventions
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- Universidad de Guanajuato
- Target Recruit Count
- 28
- Registration Number
- NCT03970668
Effect of Adding Metformin to Insulin Therapy on Pregnancy Outcomes in Women With Uncontrolled Type I Diabetes.
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2020-05-28
- Lead Sponsor
- Kasr El Aini Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03928340
- Locations
- 🇪🇬
Beniswef university hospital, Cairo, Egypt
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2023-01-20
- Target Recruit Count
- 9
- Registration Number
- NCT03904199
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Triple Therapy in T1DM
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2019-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- State University of New York at Buffalo
- Target Recruit Count
- 78
- Registration Number
- NCT03899402
- Locations
- 🇺🇸
Diabetes and Endocrinology Research Center of WNY, Williamsville, New York, United States
Study of Nasal Insulin to Fight Forgetfulness - Device Study
- Conditions
- Mild Cognitive ImpairmentCognitive Impairment
- Interventions
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT03857321
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
- Conditions
- Gestational Diabetes
- Interventions
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 124
- Registration Number
- NCT03841591
- Locations
- 🇪🇬
Ain SHams Maternity Hospital, Cairo, Abbaseya, Egypt
Intensive Versus Conventional Glycemic Control in Diabetic Foot Ulcer Healing
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Target Recruit Count
- 50
- Registration Number
- NCT03740581
- Locations
- 🇮🇳
Postgraduate Medical Institute of Medical Education and Research, Chandigarh, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.